Metrikler
Yayın
33
Açık Erişim
14
BM Sürdürülebilir Kalkınma Amaçları
Makaleler
Tümü (26)
SCI-E, SSCI, AHCI (23)
SCI-E, SSCI, AHCI, ESCI (26)
ESCI (3)
Scopus (24)
TRDizin (11)
2016
20161. Retrospective analysis of adult patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic cell transplantation: A multicenter experience of daily practice
Tekgunduz E., KAYNAR L., GÖKER H., Kaya A. H., ERMİŞ TURAK E., ELİAÇIK E., et al.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.54, sa.1, ss.41-47, 2016 (SCI-Expanded, Scopus)
2016
20162. The Prognosis of Adult Burkitt's Cell Leukemia in Real-Life Clinical Practice
Malkan Ü. Y., GÜNEŞ G., GÖKER H., HAZNEDAROĞLU İ. C., Acar K., ELİAÇIK E., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.33, sa.4, ss.281-285, 2016 (SCI-Expanded, Scopus, TRDizin)
2016
20163. Treatment of pyoderma gangrenosum with thalidomide in a myelodysplastic syndrome case
Malkan Ü. Y., GÜNEŞ G., ELİAÇIK E., HAZNEDAROĞLU İ. C.
INTERNATIONAL MEDICAL CASE REPORTS JOURNAL
, cilt.9, ss.61-64, 2016 (ESCI, Scopus)
2016
20164. The Impact of Iron Overload on Transplant-Related Complications and Prognosis of Acute Leukemias
Malkan U. Y., GÜNEŞ G., ELİAÇIK E., HAZNEDAROĞLU İ. C., Yayar O., ETGÜL S., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.26, sa.1, ss.54-60, 2016 (SCI-Expanded, Scopus, TRDizin)
2016
20165. Comparison of Myelodysplastic Syndrome Prognostic Scoring Systems
BEKTAŞ Ö., ÜNER A., ELİAÇIK E., Uz B., Isik A., ETGÜL S., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.33, sa.2, ss.119-126, 2016 (SCI-Expanded, Scopus, TRDizin)
2015
20156. High frequency of autonomous T-cell proliferation compatible with T-cell large granular lymphocytic leukemia in patients with cytopenia of unknown etiology
BEKTAŞ Ö., ÜNER A., Aydin S. M., ELİAÇIK E., Uz B., Isik A., et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY
, cilt.102, sa.2, ss.211-217, 2015 (SCI-Expanded, Scopus)
2015
20157. Bone marrow fibrosis may be an effective independent predictor of the 'TKI drug response level' in chronic myeloid leukemia
ELİAÇIK E., Isik A., Aydin C., ÜNER A., AKSU S., SAYINALP N., et al.
HEMATOLOGY
, cilt.20, sa.7, ss.392-396, 2015 (SCI-Expanded, Scopus)
2015
20158. Pharmacobiological Approach for the Clinical Development of Ruxolitinib in Myeloproliferative Neoplasms
ELİAÇIK E., Isik A., AKSU S., ÜNER A., BÜYÜKAŞIK Y., SAYINALP N., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.32, sa.2, ss.163-167, 2015 (SCI-Expanded, Scopus, TRDizin)
2015
20159. The factors affecting early death after the initial therapy of acute myeloid leukemia
Malkan Ü. Y., GÜNEŞ G., ELİAÇIK E., HAZNEDAROĞLU İ. C., ETGÜL S., Aslan T., et al.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
, cilt.8, sa.12, ss.22564-22569, 2015 (SCI-Expanded, Scopus)
2015
201510. Can red cell distribution width be a marker of disease activity in ulcerative colitis?
Ipek S., Cekic C., Alper E., Coban E., ELİAÇIK E., Arabul M., et al.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
, cilt.8, sa.8, ss.13848-13853, 2015 (SCI-Expanded, Scopus)
2015
201511. Clinicopathological associations of acquired erythroblastopenia
GÜNEŞ G., Malkan Ü. Y., YAŞAR H. A., ELİAÇIK E., HAZNEDAROĞLU İ. C., DEMİROĞLU H., et al.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
, cilt.8, sa.12, ss.22515-22519, 2015 (SCI-Expanded, Scopus)
2015
201512. Generic Imatinib Mesylate is as Effective as Original Glivec in the Clinical Management of CML
Malkan U. Y., AKSU S., Aktimur S. H., Atay H., Bektas O., BÜYÜKAŞIK Y., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.25, sa.4, ss.215-221, 2015 (SCI-Expanded, Scopus, TRDizin)
2015
201513. Potassium Abnormalities in Current Clinical Practice: Frequency, Causes, Severity and Management
Eliacik E., YILDIRIM T., Sahin U., Kizilarslanoglu C., Tapan U., Aybal-Kutlugun A., et al.
MEDICAL PRINCIPLES AND PRACTICE
, cilt.24, sa.3, ss.271-275, 2015 (SCI-Expanded, Scopus)
2015
201514. Rebound Thrombocytosis following Induction Chemotherapy Is an Independent Predictor of a Good Prognosis in Acute Myeloid Leukemia Patients Attaining First Complete Remission
Malkan Ü. Y., Gunes G., Isik A., Eliacik E., Etgul S., Aslan T., et al.
ACTA HAEMATOLOGICA
, cilt.134, sa.1, ss.32-37, 2015 (SCI-Expanded, Scopus)
2015
201515. Melanonychia Secondary to Long-Term Treatment with Hydroxycarbamide: An Essential Thrombocytosis Case
Malkan Ü. Y., GÜNEŞ G., ELİAÇIK E., Yayar O., HAZNEDAROĞLU İ. C.
CASE REPORTS IN HEMATOLOGY
, 2015 (ESCI)
2015
201516. Late Onset and Protracted Course of Steroid Refractory Chronic Graft-versus-Host Disease
GÜNEŞ G., DEMİROĞLU H., GÖKER H., Malkan Ü. Y., ELİAÇIK E., Yayar O., et al.
CASE REPORTS IN HEMATOLOGY
, 2015 (ESCI)
2014
201417. Rebound Thrombocytosis Is an Independent Predictor of Good Prognosis in AML Patients Attaining First Complete Remission
Malkan Ü. Y., GÜNEŞ G., GÖKER H., ELİAÇIK E., Isik A., SAYINALP N., et al.
BLOOD
, cilt.124, sa.21, 2014 (SCI-Expanded, Scopus)
2014
201418. Iron Overload Pattern in Multiple Myeloma at Diagnosis its Important Clinical Associations
AYDIN M. S., ELİAÇIK E.
ULUSLARARASI HEMATOLOJİ-ONKOLOJİ DERGİSİ , sa.24, ss.185-189, 2014 (SCI-Expanded, Scopus, TRDizin)
2014
201419. An Immune Thrombocytopenic Purpura-Like Picture Preceding Chronic Myelomonocytic Leukemia: A Case Series and Review of the Literature
Albayrak M., ELİAÇIK E., KORUCU B., Isik A., GÜNEŞ G., AKSU S., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.24, sa.3, ss.213-216, 2014 (SCI-Expanded, Scopus, TRDizin)
2014
201420. Vitamin B-12 Deficiency with the Absence of Anemia in Young and Middle-Aged Population
Kara A., Eliacik E., BÜYÜKAŞIK Y., ÖZCEBE O. İ., Haznedaroglu I., AKSU S., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.24, sa.3, ss.190-194, 2014 (SCI-Expanded, Scopus, TRDizin)
2014
201421. Giant Hemophilic Pseudotumor of the Iliopsoas: Case Report
MALKAN Ü. Y., Gunes G., Eliacik E., ISIK A., AKSU S., ATİLLA B., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.24, sa.4, ss.286-288, 2014 (SCI-Expanded, Scopus, TRDizin)
2013
201322. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: A single center experience
GÖKER H., Ozdemir E., UZ B., BÜYÜKAŞIK Y., Turgut M., SEREFHANOGLU S., et al.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.49, sa.3, ss.590-599, 2013 (SCI-Expanded, Scopus)
2013
201323. Co-expression of t(5;17) and t(8;21) in a Case of Acute Promyelocytic Leukemia: Review of the Literature
Uz B., ELİAÇIK E., Isik A., AKSU S., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.30, sa.4, ss.400-404, 2013 (SCI-Expanded, Scopus, TRDizin)
2013
201324. EUTOS CML prognostic scoring system predicts ELN-based 'event-free survival' better than Euro/Hasford and Sokal systems in CML patients receiving front-line imatinib mesylate
Uz B., BÜYÜKAŞIK Y., Atay H., KELKİTLİ E., Turgut M., BEKTAŞ Ö., et al.
HEMATOLOGY
, cilt.18, sa.5, ss.247-252, 2013 (SCI-Expanded, Scopus)
2013
201325. The Impact of Eltrombopag Administration on the Clinical Course of Severe Refractory Fatal Acquired Aplastic Anemia
Isik A., ELİAÇIK E., HAZNEDAROĞLU İ. C., AKSU S., SAYINALP N., BÜYÜKAŞIK Y., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.30, sa.3, ss.328-330, 2013 (SCI-Expanded, Scopus, TRDizin)
2013
201326. Long-Term Sustained Hemorrhage Due to Bone Marrow Biopsy Successfully Treated With Topical Ankaferd Hemostat in a Bleeding-Prone Patient With Secondary Amyloidosis
Uz B., SAİN GÜVEN G., Isik A., KUYUMCU M. E., BEKTAŞ Ö., ELİAÇIK E., et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
, cilt.19, sa.3, ss.338-340, 2013 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2015
20151. SUCCESSFUL TREATMENT OF RESISTANT CHRONIC GRAFT VERSUS HOST DISEASE WITH EXTRACORPOREAL PHOTOPHERESIS IN A PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENT WHO HAS UNDERGONE ALLOGENEIC STEM CELL TRANSPLANTATION
Malkan Ü. Y., GÜNEŞ G., ELİAÇIK E., Yayar O., GÖKER H., ÖZCEBE O. İ.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)
2015
20152. THE COEXISTENCE OF B-THALASSEMIA MINOR AND SICKLE CELL ANEMIA: A CASE REPORT
Malkan Ü. Y., GÜNEŞ G., ELİAÇIK E., Yayar O., DEMİROĞLU H., BÜYÜKAŞIK Y.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)
2015
20153. GENERIC IMATINIB MESYLATE IS AS EFFECTIVE AS ORIGINAL GLIVEC IN THE MANAGEMENT OF CML
AKSU S., Aktimur S. H., Arica D. C., Atay H., Bektas O., BÜYÜKAŞIK Y., et al.
20th Congress of European-Hematology-Association, Vienna, Avusturya, 11 - 14 Haziran 2015, cilt.100, ss.690, (Özet Bildiri)
2015
20154. Extramedullary relapses after allogeneic stem cell transplantation for leukemia: Clinical characteristics, cumulative incidence and risk factors
Goker H., Gunes G., Demiroglu H., Malkan Ü. Y., Haznedaroglu I., Sayinalp N., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)
2014
20145. Lower Doses of Plerixafor Use Is Sufficient to Effectively Mobilize PBSC (Peripheral Blood Hematopoetic Stem Cells) When Compared to Standard Administration
GÖKER H., ELİAÇIK E., Altuntas F., Tekgunduz E., ÖZDEMİR E., Isik A., et al.
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2014, cilt.124, (Özet Bildiri)
2014
20146. GENERIC IMATINIB MESYLATE IS AS EFFECTIVE AS ORIGINAL GLIVEC IN THE MANAGEMENT OF CML
AKSU S., AKTİMUR S., ARİCA D., ATAY M. H., BEKTAŞ Ö., BÜYÜKAŞIK Y., et al.
20th Congress of the European Hematology Association Vienna, Austria June 11-14,2015, 11 - 14 Haziran 2014, (Tam Metin Bildiri)
2014
20147. High-dose chemotherapy and autologons peripheral blood stein tell (PBSC) transplantation with initt-cryopreserved PBSCs in multiple myeloma
Goker H., Eliacik E., Buyukasik Y., Haznedaroglu I. C., Turgut M., Aksu S., et al.
50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri)